AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

Clinical trial NCT05669339 · RECRUITING

Trial details

NCT number: NCT05669339
Sponsor: University of Florida
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2024-12-02
Primary completion: 2027-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.